Fig. 5From: Gentiopicroside inhibits the progression of gastric cancer through modulating EGFR/PI3K/AKT signaling pathwayGPS inhibited GC cells proliferation and migration by inhibiting the EGFR/PI3K/AKT axis. A EdU staining kit, B Colony formation assay and C wound healing assay were performed to measure the proliferation and migration ability of GC cells treated with GPS (100 μM) and GC cells treated with GPS (100 μM) co-overexpressing EGFR plasmid. (***P < 0.001; ns, non-significant)Back to article page